Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran

Authors Shafie Pour MR, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R

Received 8 January 2019

Accepted for publication 29 April 2019

Published 7 August 2019 Volume 2019:12 Pages 1349—1354

DOI https://doi.org/10.2147/DMSO.S200867

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr Juei-Tang Cheng


MR Shafie Pour,1 T Sadeghiyeh,2 M Hadavi,3,4 M Besharati,5 R Bidaki6

1Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Hahid Sadoughi University of Medical Sciences, Yazd, Iran; 3Department of Anesthesiology, Paramedical Faculty, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 4Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 5Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 6Research Center of Addiction and Behavioral Sciences, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Introduction: The decision to start insulin therapy is often difficult. Determining the barriers against insulin therapy initiation can facilitate care and treatment strategies. The aim of this study was to evaluate the barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.
Methods: This descriptive study was conducted on 214 patients referred to the Diabetes Center of Yazd University of Medical Sciences in 2015. Participants were randomly selected, and then they completed the insulin noncompliance questionnaire (20 questions). The percentage of adherence and the factors contributing to nonadherence to insulin therapy were analyzed using descriptive statistics, the Kruskal–Wallis test, and the Mann–Whitney test.
Results: The most prevalent reason for insulin therapy refusal was expecting a new method of diabetes treatment (54.7%), followed by requiring someone else to administer the injection (19.2%), fear of needles, cost, traveling (18.7%), and stress/emotional problems (18.2%). Lack of trust in the physician was the least restrictive reason for nonadherence to insulin therapy.
Conclusion: The most common reason given for insulin therapy refusal was the lack of adequate education. Therefore, specialized educational interventions can help minimize barriers and improve patients’ outcomes.

Keywords: barriers, diabetes, insulin therapy, Yazd


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]